节点文献

人胎盘血水解液代替人红细胞水解液用作疫苗保护剂的研究

Human Placenta Blood Hydrolysate as the Stabilizer of Live Vaccine Instead of Human Red Blood Cell Hydrolysate

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 郭福全刘燕泽韩文暖

【Author】 Guo Fuquan; Liu Yanze;Han Wennuan (National Vaccine & Serum Institute, Beijing 100024 )

【机构】 卫生部北京生物制品研究所!北京100024

【摘要】 人胎盘血水解液的一般理化指标、氨基酸组成和含量均与人红细胞水解波接近。用其作为麻疹、风疹和腮腺炎疫苗的保护剂,在疫苗冻干前、冻干后及37℃1周后病毒滴度均能达到规程要求。用于制备麻疹和风疹疫苗共200余批,成品病毒滴度和37℃1周后病毒滴度均优于人红细胞水解液,说明人胎盘血水解液完全可以代替人红细胞水解液作为保护剂用于制备麻疹、风疹和腮腺炎疫苗。

【Abstract】 The general physicochemical characteristics and amino acid composition and contents of human placenta blood hydrolysate were similar to those of human red blood cell (RBC) hydrolysate. Using human placenta blood hydrolysate as stabilizer, the virus titers of measles, rubella and mumps vaccines before and after lyophilization and being stored at 37℃for I week could meet the Chinese Requirements for Biologicals. More than 200 lots of measles and rubella vaccines were prepared using human placenta blood hydrolysate as stabilizer, the result showed that the titers of the final vaccines after lyophilization and being stored at 37℃ for 1 week were significantly higher than those using human RBC hydrolysate as stabllizer. It demonstrated that human placenta blood hydrolysate could be used as stabilizer instead of human RBC hydrolysate in the production of measles, rubella and mumps vaccines.

  • 【文献出处】 中国生物制品学杂志 ,CHINESE JOURNAL OF BIOLOGICALS , 编辑部邮箱 ,1997年03期
  • 【分类号】R186
  • 【下载频次】41
节点文献中: 

本文链接的文献网络图示:

本文的引文网络